A Feasible Smart Upper Limb Rehabilitation Model for Patients With Stroke and Spinal Cord Injuries
Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Jan 10, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who have had a stroke or spinal cord injuries improve their arm movements at home. The researchers have developed a special application and robotic devices that can assist with rehabilitation exercises. Some participants will use this smart rehabilitation system, while others will follow a traditional home exercise program. The goal is to see if the new technology helps improve their ability to move, perform daily activities, and enhance their quality of life.
To be eligible for this trial, stroke patients need to be between 20 and 79 years old and have some movement difficulties due to a brain injury. For spinal cord injury patients, the age range is 20 to 65, and they should have a specific type of incomplete spinal cord injury. Participants will be monitored before and after using the rehabilitation system to track their progress. This trial is currently recruiting participants, and it's a great opportunity for those looking for new ways to enhance their recovery in a supportive environment.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: For patients with stroke
- • 20-79 years old.
- • The score of Montreal Cognitive Assessment is more than or equal to 26.
- • The unilateral hemorrhagic or ischemic participants.
- • The performance of upper limb movement is affected by damage to brain cells.
- • Inclusion Criteria: For patients with spinal cord injury
- • 20-65 years old.
- • The score of Mini-Mental Status Examination is more than or equal to 25.
- • Diagnosed as incomplete spinal cord injury at the C5 or C6 level.
- • Exclusion Criteria: For patients with stroke
- • Underwent sugery on the shoulder, elbow or wrist.
- • Severe pain in upper limb.
- • Another muscular or neurological diseases that effects motor performance.
- • Exclusion Criteria: For patients with spinal cord injury
- • Underwent sugery on the shoulder, elbow or wrist.
- • Severe pain in upper limb.
- • Another muscular or neurological diseases that effects motor performance.
About National Cheng Kung University Hospital
National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan, , Taiwan
Tainan, , Taiwan
Patients applied
Trial Officials
Li-Chieh Kuo, Ph.D
Principal Investigator
National Cheng Kung University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported